Abiy Habtewold

Importance of Ethnicity, CYP2B6 and ABCB1 Genotype for Efavirenz Pharmacokinetics and Treatment Outcomes: A Parallel-Group Prospective Cohort Study in Two Sub-Saharan Africa Populations

Eliford Ngaimisi, Abiy Habtewold, Omary Minzi et al. · PLoS ONE · 2013 · 124 citations · Full text

Veterinary Medicine, Pharmacokinetics, Pharmacology +17

High plasma efavirenz level and CYP2B6*6 are associated with efavirenz-based HAART-induced liver injury in the treatment of naïve HIV patients from Ethiopia: a prospective cohort study

Getnet Yimer, Wondwossen Amogne, Abiy Habtewold et al. · The Pharmacogenomics Journal · 2011 · 123 citations

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Pharmacogenetic & Pharmacokinetic Biomarker for Efavirenz Based ARV and Rifampicin Based Anti-TB Drug Induced Liver Injury in TB-HIV Infected Patients

Getnet Yimer, Nobuhisa Ueda, Abiy Habtewold et al. · PLoS ONE · 2011 · 123 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients

Getnet Yimer, Marcus Gry, Wondwossen Amogne et al. · PLoS ONE · 2014 · 69 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +16

Long-term effect of efavirenz autoinduction on plasma/peripheral blood mononuclear cell drug exposure and CD4 count is influenced by UGT2B7 and CYP2B6 genotypes among HIV patients

Abiy Habtewold, Wondwossen Amogne, Eyasu Makonnen et al. · Journal of Antimicrobial Chemotherapy · 2011 · 60 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16